Krish S. Krishnan - May 31, 2023 Form 4 Insider Report for Krystal Biotech, Inc. (KRYS)

Signature
/s/ Krish S. Krishnan
Stock symbol
KRYS
Transactions as of
May 31, 2023
Transactions value $
-$5,809,889
Form type
4
Date filed
6/2/2023, 06:21 PM
Previous filing
Apr 18, 2023
Next filing
Sep 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRYS Common Stock Sale -$2.19M -18.9K -1.1% $116.00 1.69M May 31, 2023 Direct F1
transaction KRYS Common Stock Sale -$668K -5.72K -0.34% $116.95 1.68M May 31, 2023 Direct F2
transaction KRYS Common Stock Sale -$47K -400 -0.02% $117.61 1.68M May 31, 2023 Direct F3
transaction KRYS Common Stock Sale -$2.34M -20.1K -1.22% $115.98 1.63M May 31, 2023 By Spouse F1, F4, F5
transaction KRYS Common Stock Sale -$533K -4.56K -0.28% $116.86 1.62M May 31, 2023 By Spouse F4, F5, F6
transaction KRYS Common Stock Sale -$35.3K -300 -0.02% $117.57 1.62M May 31, 2023 By Spouse F4, F5, F7
holding KRYS Common Stock 90K May 31, 2023 By Krishnan Spousal Trust
holding KRYS Common Stock 50K May 31, 2023 By Krishnan Family Trust F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was executed in multiple trades ranging from $115.5200 to $116.5100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F2 The transaction was executed in multiple trades ranging from $116.5200 to $117.5000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3 The transaction was executed in multiple trades ranging from $117.5500 to $117.7200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4 These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Suma Krishnan.
F5 Directly beneficially owned by Suma M. Krishnan, the spouse of the Reporting Person.
F6 The transaction was executed in multiple trades ranging from $116.5200 to $117.5100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F7 The transaction was executed in multiple trades ranging from $117.5500 to $117.6000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F8 Directly beneficially owned by the Krishnan Family Trust. The Reporting Person and his spouse are each joint beneficial owners of the trust with joint voting and investment control.